Gene · 2746
Papers4,000
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,000
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Accuracy of a Glycerol Dehydrogenase Assay for Ethylene Glycol Detection. | J Med Toxicol | 2023 | 37695470 | PubTator, text mining | PubMed |
| Metabolomics in Pulmonary Hypertension-A Useful Tool to Provide Insights into the Dark Side of a Tricky Pathology. | Int J Mol Sci | 2023 | 37686034 | PubTator, text mining | PubMed |
| Comparative Transcriptomics of Chilodonella hexasticha and C. uncinata Provide New Insights into Adaptations to a Parasitic Lifestyle and Mdivi-1 as a Potential Agent for Chilodonellosis Control. | Int J Mol Sci | 2023 | 37685862 | PubTator, text mining | PubMed |
| Coenzyme-binding pathway on glutamate dehydrogenase suggested from multiple-binding sites visualized by cryo-electron microscopy. | FEBS J | 2023 | 37682540 | PubTator, text mining | PubMed |
| Establishment and bioinformatics evaluation of the ethanol combined with palmitic acid-induced mouse hepatocyte AFLD model (the Hu-Qiu Model). | Heliyon | 2023 | 37681138 | PubTator, text mining | PubMed |
| Clostridioides difficile infection in a skilled nursing facility (SNF): cost savings of an automated, standardized probiotic antimicrobial stewardship programme (ASP) policy. | JAC Antimicrob Resist | 2023 | 37680882 | PubTator, text mining | PubMed |
| Development of a prognostic model for anoikis and identifies hub genes in hepatocellular carcinoma. | Sci Rep | 2023 | 37679418 | PubTator, text mining | PubMed |
| Emerging role of metabolic reprogramming in hyperoxia-associated neonatal diseases. | Redox Biol | 2023 | 37659187 | PubTator, text mining | PubMed |
| Glutamine metabolic reprogramming in hepatocellular carcinoma. | Front Mol Biosci | 2023 | 37635935 | PubTator, text mining | PubMed |
| Hypoglycemia in Children: Major Endocrine-Metabolic Causes and Novel Therapeutic Perspectives. | Nutrients | 2023 | 37630734 | PubTator, text mining | PubMed |
| Clostridioides difficile Infections among Pediatric Patients Hospitalized at an Oncology Department of a Tertiary Hospital in Poland. | Medicina (Kaunas) | 2023 | 37629653 | PubTator, text mining | PubMed |
| Effects of Low-Molecular-Weight Glutenin Subunit Encoded by Glu-A3 on Gluten and Chinese Fresh Noodle Quality. | Foods | 2023 | 37628123 | PubTator, text mining | PubMed |
| SIRT5 Activation and Inorganic Phosphate Binding Reduce Cancer Cell Vitality by Modulating Autophagy/Mitophagy and ROS. | Antioxidants (Basel) | 2023 | 37627630 | PubTator, text mining | PubMed |
| Roles of Oxidative Stress in Synaptic Dysfunction and Neuronal Cell Death in Alzheimer's Disease. | Antioxidants (Basel) | 2023 | 37627623 | PubTator, text mining | PubMed |
| Metabolic Heterogeneity, Plasticity, and Adaptation to "Glutamine Addiction" in Cancer Cells: The Role of Glutaminase and the GTωA [Glutamine Transaminase-ω-Amidase (Glutaminase II)] Pathway. | Biology (Basel) | 2023 | 37627015 | PubTator, text mining | PubMed |
| Pan-Cancer Identification of Prognostic-Associated Metabolic Pathways. | Biology (Basel) | 2023 | 37627013 | PubTator, text mining | PubMed |
| Emergence of the Synucleins. | Biology (Basel) | 2023 | 37626939 | PubTator, text mining | PubMed |
| The anoikis-related gene signature predicts survival accurately in colon adenocarcinoma. | Sci Rep | 2023 | 37626132 | PubTator, text mining | PubMed |
| Age-specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands. | Influenza Other Respir Viruses | 2023 | 37621921 | PubTator, text mining | PubMed |
The implication of necroptosis-related lncRNAs in orchestrating immune infiltration and predicting therapeutic efficacy in colon adenocarcinoma: an integrated bioinformatic analysis with preliminarily experimental validation. | Front Genet | 2023 | 37600653 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2746/papers?page=20